[Congressional Record Volume 172, Number 71 (Wednesday, April 22, 2026)]
[Senate]
[Page S2023]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 5336. Mr. WYDEN submitted an amendment intended to be proposed by 
him to the concurrent resolution S. Con. Res. 33, setting forth the 
congressional budget for the United States Government for fiscal year 
2026 and setting forth the appropriate budgetary levels for fiscal 
years 2027 through 2035; which was ordered to lie on the table; as 
follows:

         At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO THE 
                   DUTIES OF THE COMPTROLLER GENERAL OF THE UNITED 
                   STATES.

         The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution, 
     and make adjustments to the pay-as-you-go ledger, for one or 
     more bills, joint resolutions reported by the Committee on 
     Homeland Security and Governmental Affairs of the Senate, 
     amendments, amendments between the Houses, motions, or 
     conference reports relating to the duties of the Comptroller 
     General of the United States, which may include conducting 
     and publicly releasing a study related to economic 
     consequences of private or confidential drug pricing 
     agreements struck by any Federal department, agency, or 
     office with any pharmaceutical manufacturer, while protecting 
     proprietary pricing information, by the amounts provided in 
     such legislation for those purposes, provided that such 
     legislation would not increase the deficit over the period of 
     the total of fiscal years 2026 through 2035.
                                 ______